Literature

Literaturverzeichnis

Adams, S. E.; Dawson, K. M.; Gull, K.; Kingsman, S. M. und Kingsman, A. J. (1987): The expression of hybrid HIV:Ty virus-like particles in yeast, Nature 329 [6134], Seite 68-70.

Araki, K.; Yoshimatsu, K.; Lee, B. H.; Kariwa, H.; Takashima, I. und Arikawa, J. (2003): Hantavirus-specific CD8(+)-T-cell responses in newborn mice persistently infected with Hantaan virus, J.Virol. 77 [15], Seite 8408-8417.

Arikawa, J.; Yao, J. S.; Yoshimatsu, K.; Takashima, I. und Hashimoto, N. ( 1992): Protective role of antigenic sites on the envelope protein of Hantaan virus defined by monoclonal antibodies, Arch.Virol. 126 [1-4], Seite 271-281.

Asada, H.; Balachandra, K.; Tamura, M.; Kondo, K. und Yamanishi, K. (1989): Cross-reactive immunity among different serotypes of virus causing haemorrhagic fever with renal syndrome, J.Gen.Virol. 70 [Pt 4], Seite 819-825.

Asada, H.; Tamura, M.; Kondo, K.; Dohi, Y. und Yamanishi, K. (1988a): Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: generation of cytotoxic T lymphocytes, J.Gen.Virol. 69 [Pt 9], Seite 2179-2188.

Asada, H.; Tamura, M.; Kondo, K.; Dohi, Y. und Yamanishi, K. (1988b): Cell-mediated immunity to virus causing haemorrhagic fever with renal syndrome: generation of cytotoxic T lymphocytes, J.Gen.Virol. 69 [Pt 9], Seite 2179-2188.

Asada, H.; Tamura, M.; Kondo, K.; Okuno, Y.; Takahashi, Y.; Dohi, Y.; Nagai, T.; Kurata, T. und Yamanishi, K. (1987b ): Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice, J.Gen.Virol. 68 [Pt 7], Seite 1961-1969.

Asada, H.; Tamura, M.; Kondo, K.; Okuno, Y.; Takahashi, Y.; Dohi, Y.; Nagai, T.; Kurata, T. und Yamanishi, K. (1987c): Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice, J.Gen.Virol. 68 [Pt 7], Seite 1961-1969.

Asada, H.; Tamura, M.; Kondo, K.; Okuno, Y.; Takahashi, Y.; Dohi, Y.; Nagai, T.; Kurata, T. und Yamanishi, K. (1987d): Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice, J.Gen.Virol. 68 [Pt 7], Seite 1961-1969.

Asada, H.; Tamura, M.; Kondo, K.; Okuno, Y.; Takahashi, Y.; Dohi, Y.; Nagai, T.; Kurata, T. und Yamanishi, K. (1987e): Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice, J.Gen.Virol. 68 [Pt 7], Seite 1961-1969.

Asada, H.; Tamura, M.; Kondo, K.; Okuno, Y.; Takahashi, Y.; Dohi, Y.; Nagai, T.; Kurata, T. und Yamanishi, K. (1987a): Role of T lymphocyte subsets in protection and recovery from Hantaan virus infection in mice, J.Gen.Virol. 68 [Pt 7], Seite 1961-1969.

Avsic-Zupanc, T.; Petrovec, M.; Furlan, P.; Kaps, R.; Elgh, F. und Lundkvist, A. (1999): Hemorrhagic fever with renal syndrome in the Dolenjska region of Slovenia--a 10-year survey, Clin.Infect.Dis. 28 [4], Seite 860-865.

Avsic-Zupanc, T.; Toney, A.; Anderson, K.; Chu, Y. K. und Schmaljohn, C. (1995b): Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae, J.Gen.Virol. 76 [Pt 11], Seite 2801-2808.

Avsic-Zupanc, T.; Toney, A.; Anderson, K.; Chu, Y. K. und Schmaljohn, C. (1995a): Genetic and antigenic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bunyaviridae, J.Gen.Virol. 76 [Pt 11], Seite 2801-2808.

Avsic-Zupanc, T.; Xiao, S. Y.; Stojanovic, R.; Gligic, A.; van der Groen, G. und Leduc, J. W. (1992b ): Characterization of Dobrava virus: a hantavirus from Slovenia, Yugoslavia, J.Med.Virol. 38 [2], Seite 132-137.

Avsic-Zupanc, T.; Xiao, S. Y.; Stojanovic, R.; Gligic, A.; van der Groen, G. und Leduc, J. W. (1992a): Characterization of Dobrava virus: a hantavirus from Slovenia, Yugoslavia, J.Med.Virol. 38 [2], Seite 132-137.

Benoist, C. und Mathis, D. (1998): T-lymphocyte differentiation and biology, Paul, W. E., Fundamental Immunology , 4. Auflage, Seite 367-409, Lippincott - Raven, Philadelphia; New York.

Billiau, A. und Matthys, P. (2001a ): Modes of action of Freund's adjuvants in experimental models of autoimmune diseases, J.Leukoc.Biol. 70 [6], Seite 849-860.

Billiau, A. und Matthys, P. (2001b ): Modes of action of Freund's adjuvants in experimental models of autoimmune diseases, J.Leukoc.Biol. 70 [6], Seite 849-860.

Birnbaum, F. und Nassal, M. (1990): Hepatitis B virus nucleocapsid assembly: primary structure requirements in the core protein, J.Virol. 64 [7], Seite 3319-3330.

Borisova, G.; Arya, B.; Dislers, A.; Borschukova, O.; Tsibinogin, V.; Skrastina, D.; Eldarov, M. A.; Pumpens, P.; Skryabin, K. G. und Grens, E. (1993a): Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen, J.Virol. 67 [6], Seite 3696-3701.

Borisova, G.; Arya, B.; Dislers, A.; Borschukova, O.; Tsibinogin, V.; Skrastina, D.; Eldarov, M. A.; Pumpens, P.; Skryabin, K. G. und Grens, E. (1993b): Hybrid hepatitis B virus nucleocapsid bearing an immunodominant region from hepatitis B virus surface antigen, J.Virol. 67 [6], Seite 3696-3701.

Borisova, G.; Borschukova, Wanst O.; Mezule, G.; Skrastina, D.; Petrovskis, I.; Dislers, A.; Pumpens, P. und Grens, E. (1996): Spatial structure and insertion capacity of immunodominant region of hepatitis B core antigen, Intervirology 39 [1-2], Seite 16-22.

Borisova, G. P.; Berzins, I.; Pushko, P. M.; Pumpen, P.; Gren, E. J.; Tsibinogin, V. V.; Loseva, V.; Ose, V.; Ulrich, R.; Siakkou, H. und . (1989 ): Recombinant core particles of hepatitis B virus exposing foreign antigenic determinants on their surface, FEBS Lett. 259 [1], Seite 121-124.

Borisova, G. P.; Kalis, IaV; Pushko, P. M.; Tsibinogin, V. V. und Loseva, V. I. ( 1988): [Genetically engineered mutants of the core antigen of the human hepatitis B virus preserving the ability for native self-assembly] in Russian, Dokl.Akad.Nauk SSSR 298 [6], Seite 1474-1478.

Böttcher, B.; Wynne, S. A. und Crowther, R. A. (1997): Determination of the fold of the core protein of hepatitis B virus by electron cryomicroscopy, Nature 386 [6620], Seite 88-91.

Botten, J.; Mirowsky, K.; Kusewitt, D.; Bharadwaj, M.; Yee, J.; Ricci, R.; Feddersen, R. M. und Hjelle, B. (2000 ): Experimental infection model for Sin Nombre hantavirus in the deer mouse (Peromyscus maniculatus), Proc.Natl.Acad.Sci.U.S.A. 97 [19], Seite 10578-10583.

Brummer-Korvenkontio, M.; Henttonen, H. und Vaheri, A. (1982): Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica, Scand.J.Infect.Dis.Suppl 36, Seite 88-91.

Brummer-Korvenkontio, M.; Vaheri, A.; Hovi, T.; von Bonsdorff, C. H.; Vuorimies, J.; Manni, T.; Penttinen, K.; Oker-Blom, N. und Lähdevirta, J. (1980 ): Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection, J.Infect.Dis. 141 [2], Seite 131-134.

Chu, Y. K.; Jennings, G. B. und Schmaljohn, C. S. (1995): A vaccinia virus-vectored Hantaan virus vaccine protects hamsters from challenge with Hantaan and Seoul viruses but not Puumala virus, J.Virol. 69 [10], Seite 6417-6423.

Clarke, B. E.; Newton, S. E.; Carroll, A. R.; Francis, M. J.; Appleyard, G.; Syred, A. D.; Highfield, P. E.; Rowlands, D. J. und Brown, F. (1987 ): Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein, Nature 330 [6146], Seite 381-384.

Cohen, B. J. und Richmond, J. E. (1982 ): Electron microscopy of hepatitis B core antigen synthesized in E. coli, Nature 296 [5858], Seite 677-679.

Crotty, S.; Aubert, R. D.; Glidewell, J. und Ahmed, R. (2004): Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system, J.Immunol.Methods 286, Seite 111-122.

Cusi, M. G.; Valensin, P. E.; Donati, M. und Valassina, M. (2001 ): Neutralization of Toscana virus is partially mediated by antibodies to the nucleocapsid protein, J.Med.Virol. 63 [1], Seite 72-75.

Da Silva, D. M.; Schiller, J. T. und Kast, W. M. ( 2003a): Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines, Vaccine 21 [23], Seite 3219-3227.

Da Silva, D. M.; Schiller, J. T. und Kast, W. M. (2003b): Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccines, Vaccine 21 [23], Seite 3219-3227.

Da Silva, D. M.; Velders, M. P.; Nieland, J. D.; Schiller, J. T.; Nickoloff, B. J. und Kast, W. M. (2001a): Physical interaction of human papillomavirus virus-like particles with immune cells, Int.Immunol. 13 [5], Seite 633-641.

Da Silva, D. M.; Velders, M. P.; Nieland, J. D.; Schiller, J. T.; Nickoloff, B. J. und Kast, W. M. (2001b): Physical interaction of human papillomavirus virus-like particles with immune cells, Int.Immunol. 13 [5], Seite 633-641.

Da Silva, D. M.; Velders, M. P.; Nieland, J. D.; Schiller, J. T.; Nickoloff, B. J. und Kast, W. M. (2001c): Physical interaction of human papillomavirus virus-like particles with immune cells, Int.Immunol. 13 [5], Seite 633-641.

Dargeviciute, A.; Brus, Sjolander K.; Sasnauskas, K.; Kruger, D. H.; Meisel, H.; Ulrich, R. und Lundkvist, A. (2002): Yeast-expressed Puumala hantavirus nucleocapsid protein induces protection in a bank vole model, Vaccine 20 [29-30], Seite 3523-3531.

de Carvalho Nicacio, C.; Gonzalez, Della, V; Padula, P.; Bjorling, E.; Plyusnin, A. und Lundkvist, A. (2002): Cross-protection against challenge with Puumala virus after immunization with nucleocapsid proteins from different hantaviruses, J.Virol. 76 [13], Seite 6669-6677.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001c): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001d): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001e ): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001f): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001a): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001b): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001g): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001h): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

de Carvalho Nicacio, C.; Sällberg, M.; Hultgren, C. und Lundkvist, Å. (2001i): T-helper and humoral responses to Puumala hantavirus nucleocapsid protein: identification of T-helper epitopes in a mouse model, J.Gen.Virol. 82 [Pt 1], Seite 129-138.

DeFranco, A. L. (1998): B-lymphocyte activation, Paul, W. E., Fundamental Immunology , 4. Auflage, Seite 225-262, Lippincott - Raven, Philadelphia; New York.

Dzagurova, T.; Tkachenko, E.; Slonova, R.; Ivanov, L.; Ivanidze, E.; Markeshin, S.; Dekonenko, A.; Niklasson, B. und Lundkvist, Å. (1995): Antigenic relationships of hantavirus strains analysed by monoclonal antibodies, Arch.Virol. 140 [10], Seite 1763-1773.

Ebihara, H.; Yoshimatsu, K.; Ogino, M.; Araki, K.; Ami, Y.; Kariwa, H.; Takashima, I.; Li, D. und Arikawa, J. (2000): Pathogenicity of Hantaan virus in newborn mice: genetic reassortant study demonstrating that a single amino acid change in glycoprotein G1 is related to virulence, J.Virol. 74 [19], Seite 9245-9255.

Elgh, F.; Lundkvist, Å.; Alexeyev, O. A.; Wadell, G. und Juto, P. (1996a): A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus, J.Virol.Methods 59 [1-2], Seite 161-172.

Elgh, F.; Lundkvist, Å.; Alexeyev, O. A.; Wadell, G. und Juto, P. (1996b ): A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus, J.Virol.Methods 59 [1-2], Seite 161-172.

Ellis, D. S.; Shirodaria, P. V.; Fleming, E. und Simpson, D. I. (1988): Morphology and development of Rift Valley fever virus in Vero cell cultures, J.Med.Virol. 24 [2], Seite 161-174.

Ennis, F. A.; Cruz, J.; Spiropoulou, C. F.; Waite, D.; Peters, C. J.; Nichol, S. T.; Kariwa, H. und Koster, F. T. (1997): Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness, Virology 238 [2], Seite 380-390.

Fehr, T.; Skrastina, D.; Pumpens, P. und Zinkernagel, R. M. (1998): T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles, Proc.Natl.Acad.Sci.U.S.A 95 [16], Seite 9477-9481.

Francis, M. J.; Hastings, G. Z.; Brown, A. L.; Grace, K. G.; Rowlands, D. J.; Brown, F. und Clarke, B. E. (1990 ): Immunological properties of hepatitis B core antigen fusion proteins, Proc.Natl.Acad.Sci.U.S.A. 87 [7], Seite 2545-2549.

Gallina, A.; Bonelli, F.; Zentilin, L.; Rindi, G.; Muttini, M. und Milanesi, G. (1989 ): A recombinant hepatitis B core antigen polypeptide with the protamine-like domain deleted self-assembles into capsid particles but fails to bind nucleic acids, J.Virol. 63 [11], Seite 4645-4652.

Gedvilaite, A.; Zvirbliene, A.; Staniulis, J.; Sasnauskas, K.; Krüger, D. H. und Ulrich, R. (2004): Segments of puumala hantavirus nucleocapsid protein inserted into chimeric polyomavirus-derived virus-like particles induce a strong immune response in mice, Viral Immunol. 17 [1], Seite 51-68.

Geldmacher, A.; Schmaler, M.; Krüger, D. H. und Ulrich, R. (2004a): Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice, Viral Immunol. 17 [1], Seite 115-122.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004f): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004g): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004h): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004i): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004j): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004k): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004b): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. ( 2004c): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004d): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Geldmacher, A.; Skrastina, D.; Petrovskis, I.; Borisova, G.; Berriman, J. A.; Roseman, A. M.; Crowther, R. A.; Fischer, J.; Musema, S.; Gelderblom, H. R.; Lundkvist, Å.; Renhofa, R.; Ose, V.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (2004e): An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice, Virology 20 [1], Seite 108-119.

Goldsmith, C. S.; Elliott, L. H.; Peters, C. J. und Zaki, S. R. (1995): Ultrastructural characteristics of Sin Nombre virus, causative agent of hantavirus pulmonary syndrome, Arch.Virol. 140 [12], Seite 2107-2122.

Golovljova, I.; Brus Sjölander, K.; Lindegren, G.; Vasilenko, V.; Plyusnin, A. und Lundkvist, Å. (2002 ): Hantaviruses in Estonia, J Med Virol 68 [4], Seite 589-598.

Gött, P.; Zöller, L.; Darai, G. und Bautz, E. K. (1997): A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein, Virus Genes 14 [1], Seite 31-40.

Granoff, D. M.; Rathore, M. H.; Holmes, S. J.; Granoff, P. D. und Lucas, A. H. (1993): Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines, Vaccine 11 Suppl 1, Seite S46-S51.

Hjelle, B.; Jenison, S.; Torrez-Martinez, N.; Yamada, T.; Nolte, K.; Zumwalt, R.; MacInnes, K. und Myers, G. (1994a): A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses, J.Virol. 68 [2], Seite 592-596.

Hjelle, B.; Jenison, S.; Torrez-Martinez, N.; Yamada, T.; Nolte, K.; Zumwalt, R.; MacInnes, K. und Myers, G. (1994b): A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses, J.Virol. 68 [2], Seite 592-596.

Hobman, T. C. (1993): Targeting of viral glycoproteins to the Golgi complex, Trends Microbiol. 1 [4], Seite 124-130.

Hooper, J. W.; Custer, D. M.; Thompson, E. und Schmaljohn, C. S. (2001a): DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys, J.Virol. 75 [18], Seite 8469-8477.

Hooper, J. W.; Kamrud, K. I.; Elgh, F.; Custer, D. und Schmaljohn, C. S. (1999): DNA vaccination with hantavirus M segment elicits neutralizing antibodies and protects against seoul virus infection, Virology 255 [2], Seite 269-278.

Hooper, J. W.; Larsen, T.; Custer, D. M. und Schmaljohn, C. S. (2001b): A lethal disease model for hantavirus pulmonary syndrome, Virology 289 [1], Seite 6-14.

Hooper, J. W. und Li, D. (2001e): Vaccines against hantaviruses, Curr.Top.Microbiol.Immunol. 256 , Seite 171-191.

Hooper, J. W. und Li, D. (2001d): Vaccines against hantaviruses, Curr.Top.Microbiol.Immunol. 256, Seite 171-191.

Hooper, J. W. und Li, D. (2001c): Vaccines against hantaviruses, Curr.Top.Microbiol.Immunol. 256, Seite 171-191.

Huang, C.; Jin B.; Wang, M.; Li, E. und Sun, C. ( 1994): Hemorrhagic fever with renal syndrome: relationships between pathogenesis and cellular Immunity, J.Infect.Dis. 169, Seite 868-870.

Huggins, J. W.; Kim, G. R.; Brand, O. M. und McKee, K. T., Jr. ( 1986): Ribavirin therapy for Hantaan virus infection in suckling mice, J.Infect.Dis. 153 [3], Seite 489-497.

Hultgren, C.; Milich, D. R.; Weiland, O. und Sällberg, M. (1998): The antiviral compound ribavirin modulates the T helper (Th) 1/Th2 subset balance in hepatitis B and C virus-specific immune responses, J.Gen.Virol. 79 [Pt 10], Seite 2381-2391.

Isakson, P. C.; Pure, E.; Vitetta, E. S. und Krammer, P. H. (1982): T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells, J.Exp.Med. 155 [3], Seite 734-748.

Isegawa, Y.; Tanishita, O.; Ueda, S. und Yamanishi, K. (1994): Association of serine in position 1124 of Hantaan virus glycoprotein with virulence in mice, J.Gen.Virol. 75 [Pt 11], Seite 3273-3278.

Jantti, J.; Hilden, P.; Ronka, H.; Makiranta, V.; Keranen, S. und Kuismanen, E. (1997): Immunocytochemical analysis of Uukuniemi virus budding compartments: role of the intermediate compartment and the Golgi stack in virus maturation, J.Virol. 71 [2], Seite 1162-1172.

Jenison, S.; Yamada, T.; Morris, C.; Anderson, B.; Torrez-Martinez, N.; Keller, N. und Hjelle, B. (1994a): Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome, J.Virol. 68 [5], Seite 3000-3006.

Jenison, S.; Yamada, T.; Morris, C.; Anderson, B.; Torrez-Martinez, N.; Keller, N. und Hjelle, B. (1994b): Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome, J.Virol. 68 [5], Seite 3000-3006.

Jonsson, C. B. und Schmaljohn, C. S. (2001): Replication of hantaviruses, Curr.Top.Microbiol.Immunol. 256, Seite 15-32.

Kallio-Kokko, H.; Leveelahti, R.; Brummer-Korvenkontio, M.; Lundkvist, Å.; Vaheri, A. und Vapalahti, O. (2001a): Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells, J.Med.Virol. 65 [3], Seite 605-613.

Kallio-Kokko, H.; Leveelahti, R.; Brummer-Korvenkontio, M.; Lundkvist, Å.; Vaheri, A. und Vapalahti, O. (2001b): Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells, J.Med.Virol. 65 [3 ], Seite 605-613.

Kamrud, K. I.; Hooper, J. W.; Elgh, F. und Schmaljohn, C. S. (1999): Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing hantavirus structural genes in hamsters, Virology 263 [1], Seite 209-219.

Kanerva, M.; Mustonen, J. und Vaheri, A. (1998c): Pathogenesis of Puumala and other hantavirus infections, Rev.Med.Virol. 8 [2], Seite 67-86.

Kanerva, M.; Mustonen, J. und Vaheri, A. (1998a): Pathogenesis of Puumala and other hantavirus infections, Rev.Med.Virol. 8 [2], Seite 67-86.

Kanerva, M.; Mustonen, J. und Vaheri, A. (1998b ): Pathogenesis of Puumala and other hantavirus infections, Rev.Med.Virol. 8 [2], Seite 67-86.

Kanerva, M.; Mustonen, J. und Vaheri, A. (1998d): Pathogenesis of Puumala and other hantavirus infections, Rev.Med.Virol. 8 [2], Seite 67-86.

Kariwa, H.; Kamimura, M.; Arikawa, J.; Yoshimatsu, K.; Takashima, I. und Hashimoto, N. (1995): Characterization of the mode of Hantaan virus infection in adult mice using a nested reverse transcriptase polymerase chain reaction: transient virus replication in adult mice, Microbiol.Immunol. 39 [1], Seite 35-41.

Khaiboullina, S. F. und St.Jeor, S. C. (2002): Hantavirus immunology, Viral Immunol. 15 [4], Seite 609-625.

Klempa, B.; Schmidt, H. A.; Ulrich, R.; Kaluz, S.; Labuda, M.; Meisel, H.; Hjelle, B. und Kruger, D. H . (2003): Genetic interaction between distinct Dobrava hantavirus subtypes in Apodemus agrarius and A. flavicollis in nature, J.Virol. 77 [1], Seite 804-809.

Klempa, B.; Schütt, M.; Auste, B.; Labuda, M.; Ulrich, R.; Meisel, H. und Krüger, D. H. (2004a): First molecular identification of human Dobrava virus infection in central Europe, J Clin.Microbiol. 42 [3], Seite 1322-1325.

Klempa, B.; Schütt, M.; Auste, B.; Labuda, M.; Ulrich, R.; Meisel, H. und Krüger, D. H. (2004b): First molecular identification of human Dobrava virus infection in central Europe, J Clin.Microbiol. 42 [3], Seite 1322-1325.

Klingström, J.; Heyman, P.; Escutenaire, S.; Brus Sjölander, K.; De Jaegere, F.; Henttonen, H. und Lundkvist, Å. (2002a): Rodent host specificity of European hantaviruses: evidence of Puumala virus interspecific spillover, J.Med.Virol. 68 [4], Seite 581-588.

Klingström, J.; Heyman, P.; Escutenaire, S.; Brus Sjölander, K.; De Jaegere, F.; Henttonen, H. und Lundkvist, Å. (2002b): Rodent host specificity of European hantaviruses: evidence of Puumala virus interspecific spillover, J.Med.Virol. 68 [4], Seite 581-588.

Klingström, J. und Lundkvist, Å. (2003): Dobrava, but not Saarema hantavirus infection is lethal for suckling mice., International Conference on Negative Strand Viruses , Seite 160.

Klingström, J.; Maljkovic, I.; Zuber, B.; Rollman, E.; Kjerrström, A. und Lundkvist, Å. (2004): Vaccination of C57/BL6 mice with Dobrava hantavirus nucleocapsid protein in Freund's adjuvant induces partial protection against challenge, Vaccine 22 [29-30], Seite 4029-4034.

Klingström, J.; Plyusnin, A.; Vaheri, A. und Lundkvist, Å. (2002c): Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques, J.Virol. 76 [1], Seite 444-449.

Kratz, P. A.; Böttcher, B. und Nassal, M. (1999): Native display of complete foreign protein domains on the surface of hepatitis B virus capsids, Proc.Natl.Acad.Sci.U.S.A. 96 [5], Seite 1915-1920.

Krüger, D. H.; Ulrich, R. und Lundkvist, A. (2001): Hantavirus infections and their prevention, Microbes.Infect. 3 [13], Seite 1129-1144.

Kuismanen, E.; Saraste, J. und Pettersson, R. F. (1985): Effect of monensin on the assembly of Uukuniemi virus in the Golgi complex, J.Virol. 55 [3], Seite 813-822.

Kukkonen, S. K.; Vaheri, A. und Plyusnin, A. (2004): Tula hantavirus L protein is a 250 kDa perinuclear membrane-associated protein, J.Gen.Virol. 85 [Pt 5], Seite 1181-1189.

Lachmann, S.; Meisel, H.; Muselmann, C.; Koletzki, D.; Gelderblom, H. R.; Borisova, G.; Krüger, D. H.; Pumpens, P. und Ulrich, R. (1999): Characterization of potential insertion sites in the core antigen of hepatitis B virus by the use of a short-sized model epitope, Intervirology 42 [1], Seite 51-56. URL: PM:10393504

Lafon, M. und Lafage, M. (1987): Antiviral activity of monoclonal antibodies specific for the internal proteins N and NS of rabies virus, J.Gen.Virol. 68 [Pt 12], Seite 3113-3123.

Lähdevirta, J. (1982): Clinical features of HFRS in Scandinavia as compared with East Asia, Scand.J.Infect.Dis.Suppl 36, Seite 93-95.

Lee, H. W. (1982a): Korean hemorrhagic fever, Prog.Med Virol 28, Seite 96-113.

Lee, H. W.; Baek, L. J. und Johnson, K. M. (1982b): Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever, from wild urban rats, J.Infect.Dis. 146 [5], Seite 638-644.

Lee, H. W.; Chu, Y. K.; Woo, Y. D; An, C. N.; Kim, H.; Tkachenko, E. und Gligic, A. (1999): Vaccines against hemorrhagic fever with renal syndrome., Saluzzo J.F. und Dodet B., Factors in the emergence and control of rodent-borne viral diseases (Hantaviral and Arenaviral Diseases). Seite 147-156, Elsevier, Amsterdam.

Lee, H. W.; Lee, P. W. und Johnson, K. M. (1978a): Isolation of the etiologic agent of Korean Hemorrhagic fever, J.Infect.Dis. 137 [3], Seite 298-308.

Lee, H. W.; Lee, P. W. und Johnson, K. M. (1978c ): Isolation of the etiologic agent of Korean Hemorrhagic fever, J.Infect.Dis. 137 [3], Seite 298-308.

Lee, H. W.; Lee, P. W. und Johnson, K. M. (1978b): Isolation of the etiologic agent of Korean Hemorrhagic fever, J.Infect.Dis. 137 [3], Seite 298-308.

Lee, P. W.; Amyx, H. L.; Gibbs, C. J., Jr.; Gajdusek, D. C. und Lee, H. W. (1981): Propagation of Korean hemorrhagic fever virus in laboratory rats, Infect.Immun. 31 [1], Seite 334-338.

Levis, S.; Rowe, J. E.; Morzunov, S.; Enria, D. A. und St.Jeor, S. C. (1997): New hantaviruses causing hantavirus pulmonary syndrome in central Argentina, Lancet 349 [9057], Seite 998-999.

Lopez, N.; Padula, P.; Rossi, C.; Miguel, S.; Edelstein, A.; Ramirez, E. und Franze-Fernandez, M. T. (1997b): Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile, Virus Res. 50 [1], Seite 77-84.

Lopez, N.; Padula, P.; Rossi, C.; Miguel, S.; Edelstein, A.; Ramirez, E. und Franze-Fernandez, M. T. (1997a): Genetic characterization and phylogeny of Andes virus and variants from Argentina and Chile, Virus Res. 50 [1], Seite 77-84.

Lundkvist, Å.; Björsten, S. und Niklasson, B. (1993a ): Immunoglobulin G subclass responses against the structural components of Puumala virus, J.Clin.Microbiol. 31 [2], Seite 368-372.

Lundkvist, Å.; Björsten, S.; Niklasson, B. und Ahlborg, N . (1995): Mapping of B-cell determinants in the nucleocapsid protein of Puumala virus: definition of epitopes specific for acute immunoglobulin G recognition in humans, Clin.Diagn.Lab Immunol. 2 [1], Seite 82-86.

Lundkvist, Å.; Cheng, Y.; Brus Sjölander, K.; Niklasson, B.; Vaheri, A. und Plyusnin, A. (1997a): Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment, J.Virol. 71 [12], Seite 9515-9523.

Lundkvist, Å.; Cheng, Y.; Brus Sjölander, K.; Niklasson, B.; Vaheri, A. und Plyusnin, A. (1997c): Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment, J.Virol. 71 [12], Seite 9515-9523.

Lundkvist, Å.; Cheng, Y.; Brus Sjölander, K.; Niklasson, B.; Vaheri, A. und Plyusnin, A. (1997b): Cell culture adaptation of Puumala hantavirus changes the infectivity for its natural reservoir, Clethrionomys glareolus, and leads to accumulation of mutants with altered genomic RNA S segment, J.Virol. 71 [12], Seite 9515-9523.

Lundkvist, Å.; Fatouros, A. und Niklasson, B. (1991): Antigenic variation of European haemorrhagic fever with renal syndrome virus strains characterized using bank vole monoclonal antibodies, J.Gen.Virol. 72 [Pt 9], Seite 2097-2103.

Lundkvist, Å.; Hörling, J. und Niklasson, B. (1993b): The humoral response to Puumala virus infection (nephropathia epidemica) investigated by viral protein specific immunoassays, Arch.Virol. 130 [1-2], Seite 121-130. URL:

Lundkvist, A.; Kallio-Kokko, H.; Sjolander, K. B.; Lankinen, H.; Niklasson, B.; Vaheri, A. und Vapalahti, O. (1996): Characterization of Puumala virus nucleocapsid protein: identification of B-cell epitopes and domains involved in protective immunity, Virology 216 [2], Seite 397-406.

Lundkvist, Å.; Meisel, H.; Koletzki, D.; Lankinen, H.; Cifire, F.; Geldmacher, A.; Sibold, C.; Gött, P.; Vaheri, A.; Krüger, D. H. und Ulrich, R. (2002): Mapping of B-cell epitopes in the nucleocapsid protein of Puumala hantavirus, Viral Immunol. 15 [1], Seite 177-192.

McAleer, W. J.; Buynak, E. B.; Maigetter, R. Z.; Wampler, D. E.; Miller, W. J. und Hilleman, M. R. (1992): Human hepatitis B vaccine from recombinant yeast. 1984, Biotechnology 24, Seite 500-502.

McClain, D. J.; Summers, P. L.; Harrison, S. A.; Schmaljohn, A. L. und Schmaljohn, C. S. (2000): Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine, J.Med.Virol. 60 [1], Seite 77-85.

McElroy, A. K.; Bray, M.; Reed, D. S. und Schmaljohn, C. S. (2002): Andes virus infection of cynomolgus macaques, J.Infect.Dis. 186 [12], Seite 1706-1712.

Mertz, G. J.; Miedzinski, L.; Goade, D.; Pavia, A. T.; Hjelle, B.; Hansbarger, C. O.; Levy, H.; Koster, F. T.; Baum, K.; Lindemulder, A.; Wang, W.; Riser, L.; Fernandez, H. und Whitley, R. J. (2004): Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America, Clin.Infect.Dis. 39 [9], Seite 1307-1313.

Meyer, B. J. und Schmaljohn, C. S. (2000): Persistent hantavirus infections: characteristics and mechanisms, Trends Microbiol. 8 [2], Seite 61-67.

Mikhailov, M.; Monastyrskaya, K.; Bakker, T. und Roy, P. (1996): A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules, Virology 217 [1], Seite 323-331.

Milazzo, M. L.; Eyzaguirre, E. J.; Molina, C. P. und Fulhorst, C. F. (2002b): Maporal viral infection in the Syrian golden hamster: a model of hantavirus pulmonary syndrome, J.Infect.Dis. 186 [10], Seite 1390-1395.

Milazzo, M. L.; Eyzaguirre, E. J.; Molina, C. P. und Fulhorst, C. F. (2002a): Maporal viral infection in the Syrian golden hamster: a model of hantavirus pulmonary syndrome, J.Infect.Dis. 186 [10], Seite 1390-1395.

Milich, D. R. und McLachlan, A. (1986b): The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen, Science 234 [4782], Seite 1398-1401.

Milich, D. R. und McLachlan, A. (1986a): The nucleocapsid of hepatitis B virus is both a T-cell-independent and a T-cell-dependent antigen, Science 234 [4782], Seite 1398-1401.

Milich, D. R.; McLachlan, A.; Moriarty, A. und Thornton, G. B. (1987): Immune response to hepatitis B virus core antigen (HBcAg): localization of T cell recognition sites within HBcAg/HBeAg, J.Immunol. 139 [4], Seite 1223-1231.

Milich, D. R.; Schödel, F.; Hughes, J. L.; Jones, J. E. und Peterson, D. L. (1997a): The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype, J.Virol. 71 [3], Seite 2192-2201.

Milich, D. R.; Schödel, F.; Hughes, J. L.; Jones, J. E. und Peterson, D. L. (1997b): The hepatitis B virus core and e antigens elicit different Th cell subsets: antigen structure can affect Th cell phenotype, J.Virol. 71 [3], Seite 2192-2201.

Minutello, M.; Senatore, F.; Cecchinelli, G.; Bianchi, M.; Andreani, T.; Podda, A. und Crovari, P. (1999): Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons, Vaccine 17 [2], Seite 99-104.

Miyanohara, A.; Imamura, T.; Araki, M.; Sugawara, K.; Ohtomo, N. und Matsubara, K. (1986): Expression of hepatitis B virus core antigen gene in Saccharomyces cerevisiae: synthesis of two polypeptides translated from different initiation codons, J.Virol. 59 [1], Seite 176-180.

Morii, M.; Rothman, A. L.; Kurane, I.; Montoya, J. M.; Nolte, K. B.; Norman, J. E.; Waite, D. C.; Koster, F. T. und Ennis, F. A. (1999): High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome, J.Infect.Dis. 179 [2], Seite 295-302.

Mustonen, J.; Partanen, J.; Kanerva, M.; Pietila, K.; Vapalahti, O.; Pasternack, A. und Vaheri, A. (1998a): Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus, Scand.J.Immunol. 47 [3], Seite 277-279.

Mustonen, J.; Vapalahti, O.; Henttonen, H.; Pasternack, A. und Vaheri, A. (1998b): Epidemiology of hantavirus infections in Europe, Nephrol.Dial.Transplant. 13 [11], Seite 2729-2731.

Nakamura, T.; Yanagihara, R.; Gibbs, C. J., Jr.; Amyx, H. L. und Gajdusek, D. C. (1985a): Differential susceptibility and resistance of immunocompetent and immunodeficient mice to fatal Hantaan virus infection, Arch.Virol. 86 [1-2], Seite 109-120.

Nakamura, T.; Yanagihara, R.; Gibbs, C. J., Jr. und Gajdusek, D. C . (1985b): Immune spleen cell-mediated protection against fatal Hantaan virus infection in infant mice, J.Infect.Dis. 151 [4], Seite 691-697.

Neirynck, S.; Deroo, T.; Saelens, X.; Vanlandschoot, P.; Jou, W. M. und Fiers, W. (1999): A universal influenza A vaccine based on the extracellular domain of the M2 protein, Nat.Med. 5 [10], Seite 1157-1163.

Nemirov, K.; Vapalahti, O.; Lundkvist, Å.; Vasilenko, V.; Golovljova, I.; Plyusnina, A.; Niemimaa, J.; Laakkonen, J.; Henttonen, H.; Vaheri, A. und Plyusnin, A . (1999): Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia, J.Gen.Virol. 80 [Pt 2], Seite 371-379.

Netter, H. J.; Woo, W. P.; Tindle, R.; Macfarlan, R. I. und Gowans, E. J. (2003): Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine, Vaccine 21, Seite 2692-2697.

Nichol, S. T.; Spiropoulou, C. F.; Morzunov, S.; Rollin, P. E.; Ksiazek, T. G.; Feldmann, H.; Sanchez, A.; Childs, J.; Zaki, S. und Peters, C. J . (1993): Genetic identification of a hantavirus associated with an outbreak of acute respiratory illness, Science 262 [5135], Seite 914-917.

Ogino, M.; Yoshimatsu, K.; Ebihara, H.; Araki, K.; Lee, B. H.; Okumura, M. und Arikawa, J. (2004): Cell fusion activities of Hantaan virus envelope glycoproteins, J Virol 78 [19], Seite 10776-10782.

Padula, P. J.; Edelstein, A.; Miguel, S. D.; Lopez, N. M.; Rossi, C. M. und Rabinovich, R. D . (1998): Hantavirus pulmonary syndrome outbreak in Argentina: molecular evidence for person-to-person transmission of Andes virus, Virology 241 [2], Seite 323-330.

Papa, A.; Nemirov, K.; Henttonen, H.; Niemimaa, J.; Antoniadis, A.; Vaheri, A.; Plyusnin, A. und Vapalahti, O . (2001): Isolation of Dobrava virus from Apodemus flavicollis in Greece, J.Clin.Microbiol. 39 [6], Seite 2291-2293.

Papsidero, L. D.; Sheu, M. und Ruscetti, F. W . (1989): Human immunodeficiency virus type 1-neutralizing monoclonal antibodies which react with p17 core protein: characterization and epitope mapping, J.Virol. 63 [1], Seite 267-272.

Park, J. M.; Cho, S. Y.; Hwang, Y. K.; Um, S. H.; Kim, W. J.; Cheong, H. S. und Byun, S. M . (2000): Identification of H-2K(b)-restricted T-cell epitopes within the nucleocapsid protein of Hantaan virus and establishment of cytotoxic T-cell clones, J.Med.Virol. 60 [2], Seite 189-199.

Peeters, C. C.; Tenbergen-Meekes, A. M.; Poolman, J. T.; Beurret, M.; Zegers, B. J. und Rijkers, G. T . (1991): Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines, Infect.Immun. 59 [10], Seite 3504-3510.

Pinna, D. M.; Martinez, V. P.; Bellomo, C. M.; Lopez, C. und Padula, P. (2004): [New epidemiologic and molecular evidence of person to person transmission of hantavirus Andes Sout], Medicina (B Aires) 64 [1], Seite 43-46.

Plyusnin, A.; Krüger, D. H. und Lundkvist, Å . (2001a): Hantavirus infections in Europe, Adv.Virus Res. 57, Seite 105-136. URL:

Plyusnin, A. und Morzunov, S. P . (2001b): Virus evolution and genetic diversity of hantaviruses and their rodent hosts, Curr.Top.Microbiol.Immunol. 256, Seite 47-75.

Plyusnin, A.; Vapalahti, O.; Lankinen, H.; Lehvaslaiho, H.; Apekina, N.; Myasnikov, Y.; Kallio-Kokko, H.; Henttonen, H.; Lundkvist, Å. und Brummer-Korvenkontio, M. (1994): Tula virus: a newly detected hantavirus carried by European common voles, J.Virol. 68 [12], Seite 7833-7839.

Podda, A. (2001 ): The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine, Vaccine 19 [17-19], Seite 2673-2680.

Pumpen, P. und Grens, E . (2003): Artificial gene for chimeric virus-like particles., Khudakov, Y. E. und Fields, H. A., Artificial DNA. Methods and applications. Seite 249-327, CRC Press, New York.

Pumpens, P. und Grens, E . (2001): HBV core particles as a carrier for B cell/T cell epitopes, Intervirology 44 [2-3], Seite 98-114. URL:

Pushko, P.; Kozlovskaya, T.; Sominskaya, I.; Brede, A.; Stankevica, E.; Ose, V.; Pumpens, P. und Grens, E. (1993): Analysis of RNA phage fr coat protein assembly by insertion, deletion and substitution mutagenesis, Protein Eng. 6 [8], Seite 883-891.

Rafiq, K.; Bergtold, A. und Clynes, R . (2002a): Immune complex-mediated antigen presentation induces tumor immunity, J.Clin.Invest. 110 [1], Seite 71-79.

Rafiq, K.; Bergtold, A. und Clynes, R. (2002b): Immune complex-mediated antigen presentation induces tumor immunity, J.Clin.Invest. 110 [1], Seite 71-79.

Ravkov, E. V.; Nichol, S. T. und Compans, R. W. (1997): Polarized entry and release in epithelial cells of Black Creek Canal virus, a New World hantavirus, J.Virol. 71 [2], Seite 1147-1154.

Razanskiene, A.; Schmidt, J.; Geldmacher, A.; Ritzi, A.; Niedrig, M.; Lundkvist, Å.; Krüger, D. H.; Meisel, H.; Sasnauskas, K. und Ulrich, R. (2004): High yields of stable and highly pure nucleocapsid proteins of different hantaviruses can be generated in the yeast Saccharomyces cerevisiae, J Biotechnol. 111 [3], Seite 319-333.

Reip, A.; Haring, B.; Sibold, C.; Stohwasser, R.; Bautz, E. K.; Darai, G.; Meisel, H. und Krüger, D. H. (1995): Coding strategy of the S and M genomic segments of a hantavirus representing a new subtype of the Puumala serotype, Arch.Virol. 140 [11], Seite 2011-2026.

Riedl, P.; Stober, D.; Oehninger, C.; Melber, K.; Reimann, J. und Schirmbeck, R. (2002): Priming Th1 immunity to viral core particles is facilitated by trace amounts of RNA bound to its arginine-rich domain, J.Immunol. 168 [10], Seite 4951-4959.

Ruo, S. L.; Sanchez, A.; Elliott, L. H.; Brammer, L. S.; McCormick, J. B. und Fisher-Hoch, S. P. (1991): Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala, Arch.Virol. 119 [1-2], Seite 1-11.

Rwambo, P. M.; Shaw, M. K.; Rurangirwa, F. R. und DeMartini, J. C. (1996): Ultrastructural studies on the replication and morphogenesis of Nairobi sheep disease virus, a Nairovirus, Arch.Virol. 141 [8], Seite 1479-1492.

Salfeld, J.; Pfaff, E.; Noah, M. und Schaller, H. (1989): Antigenic determinants and functional domains in core antigen and e antigen from hepatitis B virus, J.Virol. 63 [2], Seite 798-808.

Sällberg, M.; Hughes, J.; Jones, J.; Phillips, T. R. und Milich, D. R . (2002): A malaria vaccine candidate based on a hepatitis B virus core platform, Intervirology 45 [4-6], Seite 350-361.

Schmaljohn, C. (1996): Bunyaviridae: The Viruses and Their Replication, Fields, B. N.; Knipe D.M; Howley P.M. und et.al., Fundamental Virology , third. Auflage, Seite 649-673, Lippincott - Raven Publishers, Philadelphia.

Schmaljohn, C. und Hjelle, B. (1997): Hantaviruses: a global disease problem, Emerg.Infect.Dis. 3 [2], Seite 95-104.

Schmaljohn, C.; Kamrud, K. I. und Hooper, J. W. (1999): Recombinant DNA vaccines for hantaviruses, Saluzzo J.F. und Dodet B., Factors in the emergence and control of rodent-borne viral diseases (Hantaviral and Arenaviral Diseases) , Seite 163-173, Elsevier, Amsterdam.

Schmaljohn, C. S.; Chu, Y. K.; Schmaljohn, A. L. und Dalrymple, J. M. (1990a): Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants, J.Virol. 64 [7], Seite 3162-3170.

Schmaljohn, C. S.; Chu, Y. K.; Schmaljohn, A. L. und Dalrymple, J. M. (1990b): Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants, J.Virol. 64 [7], Seite 3162-3170.

Schmaljohn, C. S.; Chu, Y. K.; Schmaljohn, A. L. und Dalrymple, J. M. (1990c): Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants, J.Virol. 64 [7], Seite 3162-3170.

Schmaljohn, C. S.; Chu, Y. K.; Schmaljohn, A. L. und Dalrymple, J. M. (1990d): Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants, J.Virol. 64 [7], Seite 3162-3170.

Schmaljohn, C. S.; Chu, Y. K.; Schmaljohn, A. L. und Dalrymple, J. M. (1990e): Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants, J.Virol. 64 [7], Seite 3162-3170.

Schneerson, R.; Barrera, O.; Sutton, A. und Robbins, J. B. (1980): Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates, J.Exp.Med. 152 [2], Seite 361-376.

Schödel, F.; Moriarty, A. M.; Peterson, D. L.; Zheng, J. A.; Hughes, J. L.; Will, H.; Leturcq, D. J.; McGee, J. S. und Milich, D. R. (1992): The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity, J.Virol. 66 [1], Seite 106-114.

Schütt, M.; Gerke, P.; Meisel, H.; Ulrich, R. und Krüger, D. H. (2001): Clinical characterization of Dobrava hantavirus infections in Germany, Clin.Nephrol. 55 [5], Seite 371-374.

Severson, W. E.; Schmaljohn, C. S.; Javadian, A. und Jonsson, C. B. (2003): Ribavirin causes error catastrophe during Hantaan virus replication, J.Virol. 77 [1], Seite 481-488.

Sibold, C.; Meisel, H.; Lundkvist, Å.; Schulz, A.; Cifire, F.; Ulrich, R.; Kozuch, O.; Labuda, M. und Krüger, D. H. (1999b): Simultaneous occurrence of Dobrava, Puumala, and Tula hantaviruses in Slovakia, Am.J.Trop.Med.Hyg. 61 [3], Seite 409-411.

Sibold, C.; Meisel, H.; Lundkvist, Å.; Schulz, A.; Cifire, F.; Ulrich, R.; Kozuch, O.; Labuda, M. und Krüger, D. H. (1999a): Simultaneous occurrence of Dobrava, Puumala, and Tula hantaviruses in Slovakia, Am.J.Trop.Med.Hyg. 61 [3], Seite 409-411.

Sibold, C.; Sparr, S.; Schulz, A.; Labuda, M.; Kozuch, O.; Lysy, J.; Kruger, D. H. und Meisel, H. (1995): Genetic characterization of a new hantavirus detected in Microtus arvalis from Slovakia, Virus Genes 10 [3], Seite 277-281.

Sibold, C.; Ulrich, R.; Labuda, M.; Lundkvist, Å.; Martens, H.; Schütt, M.; Gerke, P.; Leitmeyer, K.; Meisel, H. und Krüger, D. H. (2001b): Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species, J.Med.Virol. 63 [2], Seite 158-167.

Sibold, C.; Ulrich, R.; Labuda, M.; Lundkvist, Å.; Martens, H.; Schütt, M.; Gerke, P.; Leitmeyer, K.; Meisel, H. und Krüger, D. H. (2001a): Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species, J.Med.Virol. 63 [2], Seite 158-167.

Snapper, C. M.; Marcu, K. B. und Zelazowski, P. (1997): The immunoglobulin class switch: beyond "accessibility", Immunity. 6 [3], Seite 217-223.

Snapper, C. M.; McIntyre, T. M.; Mandler, R.; Pecanha, L. M.; Finkelman, F. D.; Lees, A. und Mond, J. J. (1992 ): Induction of IgG3 secretion by interferon gamma: a model for T cell-independent class switching in response to T cell-independent type 2 antigens, J.Exp.Med. 175 [5], Seite 1367-1371.

Snapper, C. M. und Paul, W. E. (1987): Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production, Science 236 [4804], Seite 944-947.

Spiropoulou, C. F. (2001): Hantavirus maturation, Curr.Top.Microbiol.Immunol. 256, Seite 33-46.

Stevens, T. L.; Bossie, A.; Sanders, V. M.; Fernandez-Botran, R.; Coffman, R. L.; Mosmann, T. R. und Vitatta, E. S. (1988): Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells, Nature 334, Seite 255-258.

Storni, T.; Lechner, F.; Erdmann, I.; Bachi, T.; Jegerlehner, A.; Dumrese, T.; Kundig, T. M.; Ruedl, C. und Bachmann, M. F. (2002): Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles, J.Immunol. 168 [6], Seite 2880-2886.

Street, M.; Herd, K.; Londono, P.; Doan, T.; Dougan, G.; Kast, W. M. und Tindle, R. W. (1999): Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the hepatitis B core antigen (HBcAg) c/e1-region, Arch.Virol. 144 [7], Seite 1323-1343.

Terajima, M.; Van Epps, H. L.; Li, D.; Leporati, A. M.; Juhlin, S. E.; Mustonen, J.; Vaheri, A. und Ennis, F. A. (2002b): Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus, Virus Res. 84 [1-2], Seite 67-77.

Terajima, M.; Van Epps, H. L.; Li, D.; Leporati, A. M.; Juhlin, S. E.; Mustonen, J.; Vaheri, A. und Ennis, F. A. (2002a): Generation of recombinant vaccinia viruses expressing Puumala virus proteins and use in isolating cytotoxic T cells specific for Puumala virus, Virus Res. 84 [1-2], Seite 67-77

Tindle, R. W.; Herd, K.; Londono, P.; Fernando, G. J.; Chatfield, S. N.; Malcolm, K. und Dougan, G. (1994): Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice, Virology 200 [2], Seite 547-557.

Ulrich, R.; Hjelle, B.; Pitra, C. und Krüger, D. H. (2002 ): Emerging viruses: the case 'hantavirus', Intervirology 45 [4-6], Seite 318-327.

Ulrich, R.; Lundkvist, A.; Meisel, H.; Koletzki, D.; Sjolander, K. B.; Gelderblom, H. R.; Borisova, G.; Schnitzler, P.; Darai, G. und Kruger, D. H. (1998a): Chimaeric HBV core particles carrying a defined segment of Puumala hantavirus nucleocapsid protein evoke protective immunity in an animal model, Vaccine 16 [2-3], Seite 272-280.

Ulrich, R.; Meisel, H.; Borisova, G.; Pumpen, P.; Ladhoff, A.; Soza, A. und Krüger, D. H. (1993): Characterization of chimeric core particles of HBV containing foreign epitopes., F.Brown; R.Chanock; H.S.Ginsberg und R.Lerner, Vaccines 93 , Seite 323-328, Cold Spring Harbor Laboratory Press, Cold Spring Harbor , New York.

Ulrich, R.; Nassal, M.; Meisel, H. und Krüger, D. H. (1998b): Core particles of hepatitis B virus as carrier for foreign epitopes, Adv.Virus Res. 50, Seite 141-182.

Van Epps, H. L.; Schmaljohn, C. S. und Ennis, F. A. (1999): Human memory cytotoxic T-lymphocyte (CTL) responses to Hantaan virus infection: identification of virus-specific and cross-reactive CD8(+) CTL epitopes on nucleocapsid protein, J.Virol. 73 [7], Seite 5301-5308.

Van Epps, H. L.; Terajima, M.; Mustonen, J.; Arstila, T. P.; Corey, E. A.; Vaheri, A. und Ennis, F. A. (2002a): Long-lived memory T lymphocyte responses after hantavirus infection, J.Exp.Med. 196 [5], Seite 579-588.

Van Epps, H. L.; Terajima, M.; Mustonen, J.; Arstila, T. P.; Corey, E. A.; Vaheri, A. und Ennis, F. A. (2002b): Long-lived memory T lymphocyte responses after hantavirus infection, J.Exp.Med. 196 [5], Seite 579-588.

Vapalahti, O.; Kallio-Kokko, H.; Narvanen, A.; Julkunen, I.; Lundkvist, Å.; Plyusnin, A.; Lehvaslaiho, H.; Brummer-Korvenkontio, M.; Vaheri, A. und Lankinen, H. (1995b): Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response, J.Med.Virol. 46 [4], Seite 293-303.

Vapalahti, O.; Kallio-Kokko, H.; Narvanen, A.; Julkunen, I.; Lundkvist, Å.; Plyusnin, A.; Lehvaslaiho, H.; Brummer-Korvenkontio, M.; Vaheri, A. und Lankinen, H. (1995a): Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response, J.Med.Virol. 46 [4], Seite 293-303.

Vapalahti, O.; Kallio-Kokko, H.; Salonen, E. M.; Brummer-Korvenkontio, M. und Vaheri, A. (1992): Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein, J.Gen.Virol. 73 [Pt 4], Seite 829-838.

Vapalahti, O.; Lundkvist, Å. und Vaheri, A. (2001): Human immune response, host genetics, and severity of disease, Curr.Top.Microbiol.Immunol. 256, Seite 153-169.

Vieira, P. und Rajewsky, K. (1986): The bulk of endogenously produced IgG2a is eliminated from the serum of adult C57BL/6 mice with a half-life of 6-8 days, Eur.J Immunol. 16 [7], Seite 871-874.

Vieira, P. und Rajewsky, K. (1988): The half-lives of serum immunoglobulins in adult mice, Eur.J Immunol. 18 [2], Seite 313-316.

Vlachaki, M. T.; Hernandez-Garcia, A.; Ittmann, M.; Chhikara, M.; Aguilar, L. K.; Zhu, X.; Teh, B. S.; Butler, E. B.; Woo, S.; Thompson, T. C.; Barrera-Saldana, H.; Aguilar-Cordova, E. und The, B. S. (2002): Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model, Mol.Ther. 6 [3], Seite 342-348.

Voronkova, T.; Grosch, A.; Kazaks, A.; Ose, V.; Skrastina, D.; Sasnauskas, K.; Jandrig, B.; Arnold, W.; Scherneck, S.; Pumpens, P. und Ulrich, R. (2002): Chimeric bacteriophage fr virus-like particles harboring the immunodominant C-terminal region of hamster polyomavirus VP1 induce a strong VP1-specific antibody response in rabbits and mice, Viral Immunol. 15 [4], Seite 627-643.

Wang, S.; Zang, L.; Feng, M.; Liang, Z.; Wang, S.; Zheng, S.; Zhang, L.; Jiang, Z. und Chen, D. (1997): Transmission electron microscopic study of the hemorrhagic spots in patients with epidemic hemorrhagic fever in the early stage, Ultrastruct.Pathol. 21 [3], Seite 281-287.

Wichmann, D.; Gröne, H. J.; Frese, M.; Pavlovic, J.; Anheier, B.; Haller, O.; Klenk, H. D. und Feldmann, H. (2002a): Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice, J.Virol. 76 [17], Seite 8890-8899.

Wichmann, D.; Gröne, H. J.; Frese, M.; Pavlovic, J.; Anheier, B.; Haller, O.; Klenk, H. D. und Feldmann, H. (2002b): Hantaan virus infection causes an acute neurological disease that is fatal in adult laboratory mice, J.Virol. 76 [17], Seite 8890-8899.

Wynne, S. A.; Crowther, R. A. und Leslie, A. G. (1999): The crystal structure of the human hepatitis B virus capsid, Mol.Cell 3 [6], Seite 771-780.

Xu, X.; Ruo, S. L.; McCormick, J. B. und Fisher-Hoch, S. P. (1992): Immunity to hantavirus challenge in Meriones unguiculatus induced by vaccinia-vectored viral proteins, Am.J.Trop.Med.Hyg. 47 [4], Seite 397-404.

Yamada, T.; Hjelle, B.; Lanzi, R.; Morris, C.; Anderson, B. und Jenison, S . (1995): Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): identification of an immunodominant region of the viral nucleocapsid protein, J.Virol. 69 [3], Seite 1939-1943.

Yoshimatsu, K.; Arikawa, J.; Ohbora, S. und Itakura, C . (1997): Hantavirus infection in SCID mice, J.Vet.Med.Sci. 59 [10], Seite 863-868.

Yoshimatsu, K.; Arikawa, J.; Tamura, M.; Yoshida, R.; Lundkvist, Å.; Niklasson, B.; Kariwa, H. und Azuma, I. (1996a): Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies, J.Gen.Virol. 77 [Pt 4], Seite 695-704.

Yoshimatsu, K.; Arikawa, J.; Tamura, M.; Yoshida, R.; Lundkvist, Å.; Niklasson, B.; Kariwa, H. und Azuma, I. (1996b): Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies, J.Gen.Virol. 77 [Pt 4], Seite 695-704.

Yoshimatsu, K.; Arikawa, J.; Tamura, M.; Yoshida, R.; Lundkvist, Å.; Niklasson, B.; Kariwa, H. und Azuma, I. (1996c): Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies, J.Gen.Virol. 77 [Pt 4], Seite 695-704.

Yoshimatsu, K.; Arikawa, J.; Tamura, M.; Yoshida, R.; Lundkvist, Å.; Niklasson, B.; Kariwa, H. und Azuma, I. (1996d): Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies, J.Gen.Virol. 77 [Pt 4], Seite 695-704.

Yoshimatsu, K.; Arikawa, J.; Tamura, M.; Yoshida, R.; Lundkvist, Å.; Niklasson, B.; Kariwa, H. und Azuma, I. (1996e): Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies, J.Gen.Virol. 77 [Pt 4], Seite 695-704.

Yoshimatsu, K.; Yoo, Y. C.; Yoshida, R.; Ishihara, C.; Azuma, I. und Arikawa, J. (1993): Protective immunity of Hantaan virus nucleocapsid and envelope protein studied using baculovirus-expressed proteins, Arch.Virol. 130 [3-4], Seite 365-376.

Zhang, X. K.; Takashima, I. und Hashimoto, N. (1989): Characteristics of passive immunity against hantavirus infection in rats, Arch.Virol. 105 [3-4], Seite 235-246.

Zheng, B. J.; Ng, M. H.; He, L. F.; Yao, X.; Chan, K. W.; Yuen, K. Y. und Wen, Y. M. (2001a): Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice, Vaccine 20 [30], Seite 4219-4225.

Zheng, B. J.; Ng, M. H.; He, L. F.; Yao, X.; Chan, K. W.; Yuen, K. Y. und Wen, Y. M. (2001b): Therapeutic efficacy of hepatitis B surface antigen-antibodies-recombinant DNA composite in HBsAg transgenic mice, Vaccine 20 [30], Seite 4219-4225.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
XDiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML generated:
22.08.2006